John Dobak

CEO, DermTech, Inc.

John Dobak, M.D. has served as Founder and CEO of several venture backed life science companies. He currently serves as the CEO of DermTech, Inc., the global leader in molecular and precision dermatology. Dr. Dobak also serves as the Chairman for 10xBio, LLC, a clinical stage pharmaceutical company developing drugs for dermatology. Dr. Dobak’s companies have developed and marketed products as diverse as cardiovascular catheters, surgical tools, and pharmaceuticals. These ventures have been financed by top tier venture capital firms (e.g. Kleiner Perkins) and notable private investors and have achieved exits through acquisition and IPO. Dr. Dobak and these companies are the recipients of several awards for entrepreneurship and innovation, including UCSD Connect’s Most Innovative New Product and MIT’s TR 100 top innovators under 40. Dr. Dobak is a member of the San Diego Chapter of the Young Presidents Organization. He received a Bachelor’s Degree from UCLA and a Medical Doctorate from UCSD.

My Sessions

Morning Keynote Address: Disrupting Healthcare with Genomics: Opportunities and Challenges

Disruptive genomic technologies hold great promise to dramatically improve patient care and lower costs, but they also face unique challenges related to market access and adoption. John Dobak, M.D., CEO of DermTech, will share some of the unique challenges and opportunities his company has faced bringing to market their breakthrough non-invasive skin genomics platform and […]


The Value of the Value Proposition

The key to positioning a company for financing is creating a strong company value proposition.  There are 5 basic elements to a value proposition and they are elements that all investors want to hear and understand. In this panel, we will discuss the basic elements of the value proposition and our panel will provide real […]